Quick Cases: Key Concepts in the Contemporary Management of HIV
  • Program Overview
    Quick Cases: Key Concepts in the Contemporary Management of HIV
    This collection of case-based expert commentaries reinforces core concepts relevant to the contemporary management of HIV.
  • Featured content
    This collection of case-based expert commentaries reinforces core concepts relevant to the contemporary management of HIV. Various experts provide practical perspectives on recent treatment advances and everyday clinical challenges.
  • 1
  • 2

Latest Content

10 of 22 Shown
  • Learning Module cme-icon ce-icon

    Contemporary HIV Management: A Collection of Quick Case-Based Commentaries

    This collection of case-based expert commentaries reinforces core concepts relevant to the contemporary management of HIV. Various experts provide practical perspectives on recent treatment advances and everyday clinical challenges.
    Faculty: Eric S. Daar MD, Charles B. Hicks MD, Lisa Hightow-Weidman MD, MPH, Daniel R. Kuritzkes MD, Paul E. Sax MD, Kathleen E. Squires MD, David A. Wohl MD
    Released: 11/10/2017
  • How New Data From IAS 2017 May Inform Dual-Therapy Options for HIV Treatment

    Daniel R. Kuritzkes MD - 9/12/2017 3 comments / Last Comment: 10/16/2017
    Should dual-therapy ART be considered in the first-line setting for some patients?
  • IAS 2017 Data Shed Light on the Potential Use of Investigational ART Coformulations

    Daniel R. Kuritzkes MD - 9/11/2017 2 comments / Last Comment: 10/16/2017
    How do phase III data on bictegravir and doravirine affect the potential future HIV treatment landscape? Here’s my take.
  • How New Data From IAS 2017 May Inform Use of ART in Patients With Cardiovascular or Bone Comorbidities

    Daniel R. Kuritzkes MD - 9/11/2017 3 comments / Last Comment: 11/12/2017
    Can switching ART improve cardiovascular or bone health?
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017 2 comments / Last Comment: 9/12/2017
    For a newly diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had a history of nonadherence and resistance?
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 9/12/2017
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 2 comments / Last Comment: 8/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017 3 comments / Last Comment: 7/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Adopting Lung Cancer Screening Recommendations for an HIV-Infected Individual With a Smoking History

    David A. Wohl MD - 5/31/2017
    What qualifies an HIV-infected past or current smoker for annual lung cancer screening using low-dose CT scans?
10 of 22 Shown
Show 10 More
Loading...